Ci thin cc triu chng trong iu tr chy mu di nhn
GLP-1s slow down their journey from your mouth to your bloodstream
Empowerment: When the biological drivers of hunger are better regulated, individuals often feel more in control of their eating habits
The Peptide InnOvatioN for Early diabEtes tReatment (PIONEER) phase 3 programme demonstrated the efficacy of oral semaglutide versus placebo and active comparators (including empagliflozin, sitagliptin and liraglutide) in achieving glycaemic control and weight loss, with a safety profile consistent with the GLP-1RA drug class [10,11,12,13,14,15,16,17,18,19,20,21]
This expertise ensures you receive the safest, most effective Semaglutide treatment available
No published data favors one over the other